RNS Number : 0368V
Genus PLC
09 April 2021
9 April 2021
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) has been notified that Stephen Wilson, Chief Executive, purchased 3 ordinary shares in the Company on 8 April 2021 on the London Stock Exchange at a price of 5,060 pence per share under the Company's HMRC-approved Share Incentive Plan.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, gives further detail of the number of ordinary shares purchased.
For further information please contact:
Genus:
Dan Hartley, Group General Counsel and Company Secretary Tel: +44 (0)1256 347100
Table A - Dividend Reinvestment
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a.
|
Name
|
Stephen Wilson
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
Chief Executive
|
|
b.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Genus plc
|
|
b.
|
LEI
|
54930022EOITNKSIGH56
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a.
|
Description of the
Financial instrument, type of instrument
Identification code
|
Ordinary shares of 10p each
GB0002074580
|
|
b.
|
Nature of the transaction
|
Purchase of 3 ordinary shares of 10p each under the Company's Share Incentive Plan.
|
|
c.
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
5,060p
|
3
|
|
|
d.
|
Aggregated information
·
Aggregated volume
·
Price
|
|
Average price(s)
|
Total volume(s)
|
|
5,060p
|
3
|
|
|
e.
|
Date of the transaction
|
2021-04-08
|
|
f.
|
Place of the transaction
|
London Stock Exchange, Main Market (XLON)
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
DSHUKAVRARUSRAR